Identification and control of a poliomyelitis outbreak in Xinjiang, China

New England Journal of Medicine

Volumn 369, Issue 21, 2013, Pages 1981-1990

  Luo, Hui Ming ^a   Zhang, Yong ^b   Wang, Xin Qi ^d   Yu, Wen Zhou ^g   Wen, Ning ^a   Yan, Dong Mei ^b   Wang, Hua Qing ^a   Wushouer, Fuerhati ^d   Wang, Hai Bo ^a   Xu, Ai Qiang ^f   Zheng, Jing Shan ^a   Li, De Xin ^b   Cui, Hui ^d   Wang, Jian Ping ^e   Zhu, Shuang Li ^b   Feng, Zi Jian ^c   Cui, Fu Qiang ^a   Ning, Jing ^d   Hao, Li Xin ^a   Fan, Chun Xiang ^a   Ning, Gui Jun ^a   Yu, Hong Jie ^a   Wang, Shi Wen ^b   Liu, Da Wei ^a   Wang, Dong Yan ^b   Fu, Jian Ping ^e   Gou, Ai Li ^d   Zhang, Guo Min ^a   Huang, Guo Hong ^b   Chen, Yuan Sheng ^a   Mi, Sha Sha ^e   Liu, Yan Min ^a   Yin, Da Peng ^a   Zhu, Hui ^b   Fan, Xin Chun ^d   Li, Xin Lan ^d   Ji, Yi Xin ^b   Li, Ke Li ^a   Tang, Hai Shu ^d   Xu, Wen Bo ^b   Wang, Yu ^a   Yang, Wei Zhong ^a   more..

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b BEIJING HOSPITAL   (China)

^c China CDC   (China)

^d Expanded Programme on Immunization   (China)

^e SHENZHEN CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^f Shandong Center for Disease Control and Prevention   (China)

^g Shandong Center for Disease Control and Prevention ^*

Author keywords

[No Author keywords available]

Indexed keywords

ORAL POLIOMYELITIS VACCINE; PROTEIN VP1;

ACUTE DISEASE; ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SURVEILLANCE; EPIDEMIC; FEMALE; FLACCID PARALYSIS; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; MALE; PAKISTAN; POLIOMYELITIS; POLIOMYELITIS VIRUS 1; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEQUENCE ANALYSIS; VACCINATION; VIRUS IDENTIFICATION; VIRUS ISOLATION;

EID: 84889871122     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1303368     Document Type: Article

References (27)

1. Global eradication of poliomyelitis by the year 2000. Wkly Epidemiol Rec 1988;63:161-2.
2. Expanded programme on immunization: poliomyelitis in 1987, 1988, and 1989. Wkly Epidemiol Rec 1991;66:49-54.
3. Aylward B, Tangermann R. The global polio eradication initiative: lessons learned and prospects for success. Vaccine 2011;29:Suppl 4:D80-D85.
4. Tracking progress towards global polio eradication, 2010-2011. Wkly Epidemiol Rec 2012;87:153-60.
5. National Bureau of Statistics of China. China statistical yearbook. Beijing: China Statistics Press, 2012:101-20.
6. Liang X, Zhang Y, Xu W, et al. An outbreak of poliomyelitis caused by type 1 vaccine-derived poliovirus in China. J Infect Dis 2006;194:545-51.
7. Chiba Y, Hikita K, Matuba T, et al. Active surveillance for acute flaccid paralysis in poliomyelitis high-risk areas in southern China. Bull World Health Organ 2001;79:103-10.
8. From the Centers for Disease Control and Prevention: importation of wild poliovirus into Qinghai Province - China, 1999. JAMA 2000;283:1414-5.
9. Polio laboratory manual, 4th ed. Geneva: World Health Organization, 2004.
10. Zhang Y, Yan D, Zhu S, et al. Type 2 vaccine-derived poliovirus from patients with acute flaccid paralysis in China: current immunization strategy effectively prevented its sustained transmission. J Infect Dis 2010;202:1780-8.
11. Grassly NC, Wenger J, Durrani S, et al. Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control study. Lancet 2007;369:1356-62. [Erratum, Lancet 2007;369:1790.]
12. Posey DL, Linkins RW, Oliveria MJ, Monteiro D, Patriarca PA. The effect of diarrhea on oral poliovirus vaccine failure in Brazil. J Infect Dis 1997;175:Suppl 1:S258-S263.
13. Resolutions (WHA59.1, eradication of poliomyelitis). Global Polio Eradication Initiative. (http://www.polioeradication.org/Portals/0/Document/ Resources/WHA59-1-Eradication-poliomyelitis.pdf).
14. Francis PT. Protective efficacy of a monovalent oral type 1 poliovirus vaccine. Lancet 2007;370:129-30.
15. Resurgence of wild poliovirus type 1 transmission and consequences of importation - 21 countries, 2002-2005. MMWR Morb Mortal Wkly Rep 2006;55:145-50.
16. Outbreaks following wild poliovirus importations - Europe, Africa, and Asia, January 2009-September 2010. MMWR Morb Mortal Wkly Rep 2010;59:1393-9.
17. Outbreak of poliomyelitis in Tajikistan in 2010: risk for importation and impact on polio surveillance in Europe? Euro Surveill 2010;15(17):pii:19558.
18. Poliomyelitis in Tajikistan: first importation since Europe certified polio-free. Wkly Epidemiol Rec 2010;85:157-8.
19. Le Menach A, Llosa AE, Mouniaman-Nara I, et al. Poliomyelitis outbreak, Pointe-Noire, Republic of the Congo, September 2010-February 2011. Emerg Infect Dis 2011;17:1506-9.
20. Progress in interrupting wild poliovirus circulation in countries with re-established transmission: Africa, 2009-2010. Wkly Epidemiol Rec 2011;86:104-10.
21. World Health Organization. Outbreak of type-1 wild poliovirus in adults, Namibia, 2006. Wkly Epidemiol Rec 2006;81:425-30.
22. Outbreak of polio in adults - Namibia, 2006. MMWR Morb Mortal Wkly Rep 2006;55:1198-201.
23. Prevots DR, Ciofi degli Atti ML, Sallabanda A, et al. Outbreak of paralytic poliomyelitis in Albania, 1996: high attack rate among adults and apparent interruption of transmission following nationwide mass vaccination. Clin Infect Dis 1998;26:419-25.
24. Arya A. Outbreak of poliomyelitis in Albania and neighboring countries in 1996. J Clin Microbiol 1999;37:276.
25. Oostvogel PM, Rumke HC, Conyn-Van Spaendonck MA, van der Avoort HG, Leeuwenburg J, van Loon AM. Poliovirus circulation among schoolchildren during the early phase of the 1992-1993 poliomyelitis outbreak in The Netherlands. J Infect Dis 2001;184:1451-5.
26. Conyn-van Spaendonck MA, Oostvogel PM, van Loon AM, van Wijngaarden JK, Kromhout D. Circulation of poliovirus during the poliomyelitis outbreak in The Netherlands in 1992-1993. Am J Epidemiol 1996;143:929-35.
27. Oostvogel PM, van Wijngaarden JK, van der Avoort HG, et al. Poliomyelitis outbreak in an unvaccinated community in The Netherlands, 1992-93. Lancet 1994;344:665-70.